Amarillo Biosciences and Intas Pharmaceuticals Sign License and Supply Agreement to Use Oral Interferon to Treat ... (Marketwire via Yahoo! Finance)

4 March 2010, 8:31 am

AMARILLO, TX--(Marketwire - 03/04/10) - Amarillo Biosciences, Inc. (ABI) (OTC.BB: AMAR - News ) today announced that it has executed a license and supply agreement with Intas Pharmaceuticals Limited (Intas), one of the top 20 pharmaceutical companies in India. Intas plans to launch a double-blind, placebo-controlled Phase 3 clinical trial of ABI's orally administered interferon-alpha lozenges in ...... Read More »

More Topics from "News"

• BRA Talk Exhibit Open at Wolf Creek Heritage Museum (High Plains Observer)
• Eye on Austin: Ethnicity an apparent factor in loss (Amarillo Globe-News)
• Red Cross Month (KVII 7 Amarillo)
• Pentagon shooter's TX road stop raised parents' alarm (ABC 13 Houston)
• New Program for Low-Income Offenders (KFDA-TV Amarillo)
• Super 8 Motel Robbed in Amarillo (KFDA-TV Amarillo)
• Deadly Crash on Loop 335 in Amarillo (KFDA-TV Amarillo)
• Temporary Sign Grace Period Ends Friday in Amarillo (KFDA-TV Amarillo)
• Texas Unemployment Rate - Amarillo Jobless Jump (KFDA-TV Amarillo)